Romero, C., Mathew, S., Wasinski, B., Reed, B., Brody, A., Dawood, R., . . . Levy, P. D. (2021). Angiotensin‐converting enzyme inhibitors increase anti‐fibrotic biomarkers in African Americans with left ventricular hypertrophy. The journal of clinical hypertension (Greenwich, Conn.), 23(5), 1008-1016. https://doi.org/10.1111/jch.14206
Chicago Style (17th ed.) CitationRomero, Cesar, et al. "Angiotensin‐converting Enzyme Inhibitors Increase Anti‐fibrotic Biomarkers in African Americans with Left Ventricular Hypertrophy." The Journal of Clinical Hypertension (Greenwich, Conn.) 23, no. 5 (2021): 1008-1016. https://doi.org/10.1111/jch.14206.
MLA (9th ed.) CitationRomero, Cesar, et al. "Angiotensin‐converting Enzyme Inhibitors Increase Anti‐fibrotic Biomarkers in African Americans with Left Ventricular Hypertrophy." The Journal of Clinical Hypertension (Greenwich, Conn.), vol. 23, no. 5, 2021, pp. 1008-1016, https://doi.org/10.1111/jch.14206.